Diagnosis of NKX2-5 mutations typically involves genetic testing, which can be done through blood samples or other tissues. Techniques such as Sanger sequencing or next-generation sequencing (NGS) are commonly used to identify mutations. Prenatal diagnosis is also possible in some cases, allowing for early intervention and planning.
